| abstract |
The present description relates to compounds, forms, and pharmaceutical compositions nthereof and methods of using such compounds, forms, or compositions thereof for treating or nameliorating Huntington's disease. nA X B nN-N n(I) nIn particular, the present description relates to substituted monocyclic heteroaryl ncompounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using nsuch compounds, forms, or compositions thereof for treating or ameliorating Huntington's ndisease. n213 |